Cancers | Free Full-Text | Administering Docetaxel for Metastatic Hormone-Sensitive Prostate Cancer 1–6 Days Compared to More Than 14 Days after the Start of LHRH Agonist Is Associated with Better Clinical Outcomes
How to Treat Prostate Cancer With Androgen Deprivation and Minimize Cardiovascular Risk: A Therapeutic Tightrope | JACC: CardioOncology
Docetaxel Versus Surveillance After Radical Radiotherapy for Intermediate- or High-risk Prostate Cancer—Results from the Prospective, Randomised, Open-label Phase III SPCG-13 Trial - ScienceDirect
Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations | Prostate Cancer and Prostatic Diseases
Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline - American Urological Association
Enzalutamide therapy for advanced prostate cancer: efficacy, resistance and beyond in: Endocrine-Related Cancer Volume 26 Issue 1 (2019)
Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol - The
Sequencing of Systemic Therapies in the Management of Advanced Prostate Cancer in India: a Delphi-Based Consensus | Oncology and Therapy
Advanced Prostate Cancer: AUA/SUO Guideline - American Urological Association
Full article: Docetaxel radiosensitizes castration-resistant prostate cancer by downregulating CAV-1
Cardiovascular Safety of Degarelix Versus Leuprolide for Advanced Prostate Cancer: The PRONOUNCE Trial Study Design - ScienceDirect
Recent Advances in the Management of Metastatic Prostate Cancer | JCO Oncology Practice
Current and Future Management of Locally Advanced and Metastatic Prostate Cancer
Modern treatment of metastatic prostate cancer | Tidsskrift for Den norske legeforening
Prostate Cancer: Hormonal Therapy (Androgen Ablation)
Prostate Cancer - TREATMENT - Uroweb
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology in: Journal of the National Comprehensive Cancer Network Volume 17 Issue 5 (2019)
![PDF] Modern treatment of metastatic prostate cancer. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/6ce0a90e6587180ba0676081483bbfd434dc2604/2-Figure1-1.png "PDF] Modern treatment of metastatic prostate cancer. | Semantic Scholar")
PDF] Modern treatment of metastatic prostate cancer. | Semantic Scholar
Prostate Cancer - TREATMENT - Uroweb
A Clinically-Achievable Injectable and Sprayable in Situ Lyotropic Liquid Crystalline Platform in Treating Hormone-Sensitive and Castration-Resistant Prostate Cancer | ACS Nano
Pharmaceuticals | Free Full-Text | The Current Therapeutic Landscape for Metastatic Prostate Cancer
